![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Specialities: Essential Thrombocythemia, Myelofibrosis, Polycythemia Vera, Leukemia, Essential Thrombocythemia, Acute Myeloid Leukemia, Myeloproliferative Neoplasm
Spoken languages: English, Spanish
I am a hematologist by training and a physician-scientist conducting laboratory research to identify curative approaches to the treatment of myeloproliferative neoplasms (MPNs). When I am not in the laboratory, I take care of patients with blood cancers who are admitted to the hospital. I strive to provide my patients with the best available therapies, which also motivates me to research new and improved treatment strategies. I am proud to be a part of the multidisciplinary hematologic malignancy program at Weill Cornell Medicine dedicated to continually advancing care for our patients.
Daniel Choi, MD, is an Instructor in Medicine at Weill Cornell Medical College and an Assistant Attending Physician at the New York-Presbyterian Hospital. Dr. Choi earned his medical degree from the Icahn School of Medicine at Mount Sinai in New York in 2016. He completed his residency training in Internal Medicine at Montefiore Medical Center in the Bronx in 2019 and his fellowship training in Hematology and Medical Oncology at NewYork-Presbyterian Hospital/Weill Cornell Medicine in 2022.
Dr. Choi is a physician-scientist conducting laboratory research focused on the stem cell biology of myeloproliferative neoplasms (MPNs). In addition to his laboratory research, he specializes in the clinical care of patients with myeloid malignancies including MPNs and leukemias at Weill Cornell Medicine.
Weill Cornell Medicine: 425 E 61st St 8th floor, New York, NY 10065, USA
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
Together we care.
Together we cure.
![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}